Hadas Reuveni
Technik-/Wissenschafts-/F&E-Leiter bei PURPLE BIOTECH LTD
Aktive Positionen von Hadas Reuveni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PURPLE BIOTECH LTD | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | - |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Vorstandsvorsitzender | - | - |
Gründer | - | - |
Karriereverlauf von Hadas Reuveni
Ehemalige bekannte Positionen von Hadas Reuveni
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Vorstandsvorsitzender | 01.01.2005 | 01.01.2012 |
KERYX BIOPHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.01.2004 |
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Direktor/Vorstandsmitglied | 01.07.2006 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.07.2006 | - | |
Gründer | 01.06.2010 | - |
Ausbildung von Hadas Reuveni
The Hebrew University of Jerusalem | Doctorate Degree |
Statistik
International
Israel | 6 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Founder | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PURPLE BIOTECH LTD | Health Technology |
Private Unternehmen | 4 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Health Technology |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Retail Trade |
- Börse
- Insiders
- Hadas Reuveni
- Erfahrung